Peter Ruane, MD
Enriched profileMedical Director and Founder, Ruane Clinical Research · Ruane Clinical Research
Peter Ruane is Medical Director and Founder, Ruane Clinical Research at Ruane Clinical Research. OpenAlex indexes 139 publications with 13,845 citations (h-index 51); ClinicalTrials.gov lists 3 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Infectious Disease profiles in the findmyKOL directory.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Peter Ruane, MD, is Medical Director and Founder, Ruane Clinical Research. The public record shows 139 publications with 13,845 citations (h-index 51), centered on HIV. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 36 companies.
- Most recent indexed publication: 2019 · Journal of viral hepatitis
- Top research focus: HIV
- 3 registered trials on ClinicalTrials.gov
- Open Payments reporting from 36 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:
- Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Sponsor: Peter J. Ruane, M.D., Inc.
Industry payments
Updated 27 Aug 2026
36 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year202541 payments
- Gilead Sciences, Inc.Program year20259 payments
- Amgen Inc.Program year202510 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
46.4%Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor13.4%Descovy83%Triumeq17%Part D<11 patientsProtease Inhibitor10%Prezcobix51%Symtuza31%Prezista17%Part D<11 patientsCardiovascular
19.4%Statin8.4%Rosuvastatin Calcium56%Atorvastatin Calcium44%Part D<11 patientsAngiotensin receptor blocker (ARB)6%Losartan Potassium57%Olmesartan Medoxomil43%Part D<11 patientsNervous system
9.1%Gabapentinoids6%Gabapentin100%Part D≥11 patientsSSRI3.1%Trazodone Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/company/ruane-clinical-research
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
croiwebcasts.org/p/2020croi/croi/39
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →croiwebcasts.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
University College Dublin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →suite401.com ↗ - Internal Medicine Residency
Mayo Clinic (Rochester, MN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →suite401.com ↗ - Research and Clinical Fellowship in Infectious Diseases
West Los Angeles Veterans Affairs Medical Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →suite401.com ↗ - Board Certified
Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →suite401.com ↗
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ruaneclinicalresearch.com ↗
- Medical Director and Founder
Ruane Clinical Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ruaneclinicalresearch.com ↗ - Physician
Ruane Medical & Liver Health Institute (HIV, hepatitis B/C, NASH, PrEP)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ruanemedical.com ↗
Secondary affiliations
appointments beyond the home institution- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cedars-sinai.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ruanemedical.com ↗
- Suite 401 Medical Office
5901 W Olympic Blvd, Los Angeles, CA (clinical practice)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →suite401.com ↗
Media & interviews
press, podcasts and appearances- Speaker/presenter
"Therapeutic Interventions for HIV Treatment and Eradication" session, CROI 2020 (Conference on Retroviruses and Opportunistic Infections) webcast
2020provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →croiwebcasts.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Yousef Khader
Jordan University of Science and Technology
Andrew Rambaut
University of Edinburgh
Olayinka Stephen Ilesanmi
University College Hospital
Maysaa El Sayed Zaki
Mansoura University